These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 23791707)

  • 1. γ-Secretase inhibitors and modulators.
    Golde TE; Koo EH; Felsenstein KM; Osborne BA; Miele L
    Biochim Biophys Acta; 2013 Dec; 1828(12):2898-907. PubMed ID: 23791707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
    Crump CJ; Johnson DS; Li YM
    Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not.
    Lessard CB; Rodriguez E; Ladd TB; Minter LM; Osborne BA; Miele L; Golde TE; Ran Y
    Alzheimers Res Ther; 2020 May; 12(1):61. PubMed ID: 32430033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase in Alzheimer's disease.
    Hur JY
    Exp Mol Med; 2022 Apr; 54(4):433-446. PubMed ID: 35396575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. gamma-Secretase as a therapeutic target in Alzheimer's disease.
    Guardia-Laguarta C; Pera M; Lleó A
    Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate γ-secretase function in generating Alzheimer-causing Aβ peptides.
    Liu L; Lauro BM; Wolfe MS; Selkoe DJ
    J Biol Chem; 2021; 296():100393. PubMed ID: 33571524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate-targeting gamma-secretase modulators.
    Kukar TL; Ladd TB; Bann MA; Fraering PC; Narlawar R; Maharvi GM; Healy B; Chapman R; Welzel AT; Price RW; Moore B; Rangachari V; Cusack B; Eriksen J; Jansen-West K; Verbeeck C; Yager D; Eckman C; Ye W; Sagi S; Cottrell BA; Torpey J; Rosenberry TL; Fauq A; Wolfe MS; Schmidt B; Walsh DM; Koo EH; Golde TE
    Nature; 2008 Jun; 453(7197):925-9. PubMed ID: 18548070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fast growing spectrum of biological functions of γ-secretase in development and disease.
    Jurisch-Yaksi N; Sannerud R; Annaert W
    Biochim Biophys Acta; 2013 Dec; 1828(12):2815-27. PubMed ID: 24099003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP.
    Weissmiller AM; Natera-Naranjo O; Reyna SM; Pearn ML; Zhao X; Nguyen P; Cheng S; Goldstein LS; Tanzi RE; Wagner SL; Mobley WC; Wu C
    PLoS One; 2015; 10(2):e0118379. PubMed ID: 25710492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. γ-Secretase and its modulators: Twenty years and beyond.
    Xia W
    Neurosci Lett; 2019 May; 701():162-169. PubMed ID: 30763650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
    Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
    J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γ-Secretase modulators show selectivity for γ-secretase-mediated amyloid precursor protein intramembrane processing.
    Weber TA; Lundkvist J; Wanngren J; Kvartsberg H; Jin S; Larssen P; Wu D; Oliveira DV; Minta K; Brinkmalm G; Zetterberg H; Blennow K; Nordvall G; Winblad B; Portelius E; Karlström H
    J Cell Mol Med; 2022 Feb; 26(3):880-892. PubMed ID: 34931449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein.
    Ben Halima S; Mishra S; Raja KMP; Willem M; Baici A; Simons K; Brüstle O; Koch P; Haass C; Caflisch A; Rajendran L
    Cell Rep; 2016 Mar; 14(9):2127-2141. PubMed ID: 26923602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-Secretase Inhibitors and Modulators Induce Distinct Conformational Changes in the Active Sites of γ-Secretase and Signal Peptide Peptidase.
    Gertsik N; Chau DM; Li YM
    ACS Chem Biol; 2015 Aug; 10(8):1925-31. PubMed ID: 26030233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γ-Secretase inhibitors and modulators for Alzheimer's disease.
    Wolfe MS
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):89-98. PubMed ID: 22122056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonspecificity of binding of gamma-secretase modulators to the amyloid precursor protein.
    Beel AJ; Barrett P; Schnier PD; Hitchcock SA; Bagal D; Sanders CR; Jordan JB
    Biochemistry; 2009 Dec; 48(50):11837-9. PubMed ID: 19928774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning by failing: ideas and concepts to tackle γ-secretases in Alzheimer's disease and beyond.
    De Strooper B; Chávez Gutiérrez L
    Annu Rev Pharmacol Toxicol; 2015; 55():419-37. PubMed ID: 25292430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of γ-Secretase Inhibitors for the Treatment of Diverse Disease Conditions through Inhibition of Notch Signaling Pathway.
    Mondal A; Bose S; Banerjee S; Pal D
    Curr Drug Targets; 2021; 22(15):1799-1807. PubMed ID: 33992061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site geometry stabilization of a presenilin homolog by the lipid bilayer promotes intramembrane proteolysis.
    Feilen LP; Chen SY; Fukumori A; Feederle R; Zacharias M; Steiner H
    Elife; 2022 May; 11():. PubMed ID: 35579427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in gamma-secretase modulation.
    Pissarnitski D
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):392-402. PubMed ID: 17659480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.